ab11089 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab11089 は 7 報の論文で使用されています。

  • Wang Q  et al. Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2a. Nat Commun 9:559 (2018). IHC-P ; Mouse . PubMed: 29422647
  • Frazier JP  et al. Multidrug Analyses in Patients Distinguish Efficacious Cancer Agents Based on Both Tumor Cell Killing and Immunomodulation. Cancer Res 77:2869-2880 (2017). IHC-P ; Dog . PubMed: 28364003
  • Komdeur FL  et al. CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. Oncoimmunology 6:e1338230 (2017). PubMed: 28932636
  • Kohanbash G  et al. Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. J Clin Invest 127:1425-1437 (2017). PubMed: 28319047
  • Marquardt N  et al. Fetal CD103+ IL-17-Producing Group 3 Innate Lymphoid Cells Represent the Dominant Lymphocyte Subset in Human Amniotic Fluid. J Immunol 197:3069-3075 (2016). PubMed: 27591320
  • Burudi EM  et al. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J Virol 76:12233-41 (2002). PubMed: 12414962
  • Alterio de Goss M  et al. Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells. J Virol 72:7733-44 (1998). PubMed: 9733809

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録